GGrantIndex
← Leaderboards

Nam V Vo

University Of Pittsburgh At Pittsburgh

$9,841,127
Attributed
$11,374,931
Total exposure
13
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $21.3M · FY201025
$25M$18.8M$12.5M$6.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$34,612,239 · 15

By mechanism

U19$26,613,637 · 3
R01$4,528,788 · 3
UC2$3,141,808 · 8
R21$328,006 · 1

Top collaborators

Most similar at University Of Pittsburgh At Pittsburgh

Same institution · by research overlap

Others in their field

Top investigators on “Phenotype

Research focus

PhenotypeDisabilityPathway InteractionsBack PainLow Back PainSuccessCharacteristicsInnovationVertebral ColumnFutureResearch PersonnelQuality Of LifeChronic Low Back PainComplexGeneticPain PatientIntervertebral Disc StructureChronicBiologicalIntervertebral Disk DegenerationCellsHealingMouse ModelBiomechanics

Grant awards (29)

Whole person experience of pain: Novel integration with low back pain phenotypes$1,570,904
UC2 · FY2025 · AR
Core-004$512,812
UC2 · FY2025 · AR
Mechanisms of Cellular Senescence Driving Intervertebral Disc Aging through Local Cell Autonomous and Systemic Non-Cell Autonomous Processes$474,997
R01 · FY2025 · AG · contact PI
Metabolic Symbiosis: Lactate as an Epigenetic Regulator and a Biofuel in Age-dependent Intervertebral Disc Degeneration$354,750
R01 · FY2025 · AR · contact PI
Core-001$339,467
UC2 · FY2025 · AR
Core-003$260,569
UC2 · FY2025 · AR
Core-005$180,238
UC2 · FY2025 · AR
Core-002$104,040
UC2 · FY2025 · AR
Project-002$92,700
UC2 · FY2025 · AR
Admin-Core-001$81,078
UC2 · FY2025 · AR
Mechanisms of Cellular Senescence Driving Intervertebral Disc Aging through Local Cell Autonomous and Systemic Non-Cell Autonomous Processes$504,169
R01 · FY2024 · AG · contact PI
Metabolic Symbiosis: Lactate as an Epigenetic Regulator and a Biofuel in Age-dependent Intervertebral Disc Degeneration$406,505
R01 · FY2024 · AR · contact PI
HEALing LB3P: Profiling Biomechanical, Biological and Behavioral phenotypes$4,500,000
U19 · FY2023 · AR
Mechanisms of Cellular Senescence Driving Intervertebral Disc Aging through Local Cell Autonomous and Systemic Non-Cell Autonomous Processes$526,910
R01 · FY2023 · AG · contact PI
Metabolic Symbiosis: Lactate as an Epigenetic Regulator and a Biofuel in Age-dependent Intervertebral Disc Degeneration$408,041
R01 · FY2023 · AR · contact PI
Metabolic Symbiosis: Lactate as an Epigenetic Regulator and a Biofuel in Age-dependent Intervertebral Disc Degeneration$327,408
R01 · FY2022 · AR · contact PI
HEALing LB3P: Profiling Biomechanical, Biological and Behavioral phenotypes$176,168
U19 · FY2021 · AR
HEALing LB3P: Profiling Biomechanical, Biological and Behavioral phenotypes$134,064
U19 · FY2021 · AR
HEALing LB3P: Profiling Biomechanical, Biological and Behavioral phenotypes$396,214
U19 · FY2020 · AR · contact PI
Influence of inflammation-related genetic variants on PT treatment response in a population affected by CLBP$100,000
U19 · FY2020 · AR
HEALing LB3P: Profiling Biomechanical, Biological and Behavioral phenotypes$16,756,172
U19 · FY2019 · AR
HEALing LB3P: Profiling Biomechanical, Biological and Behavioral phenotypes$4,551,019
U19 · FY2019 · AR · contact PI
The role of cellular senescence in intervertebral disc aging$313,486
R01 · FY2017 · AG · contact PI
The role of cellular senescence in intervertebral disc aging$313,486
R01 · FY2016 · AG · contact PI
The role of cellular senescence in intervertebral disc aging$304,081
R01 · FY2015 · AG · contact PI
The role of cellular senescence in intervertebral disc aging$295,331
R01 · FY2014 · AG · contact PI
The role of cellular senescence in intervertebral disc aging$299,624
R01 · FY2013 · AG · contact PI
MECHANISM OF DISC PROTEOGLYCAN LOSS IN A MOUSE MODEL OF ACCELERATED AGING$149,262
R21 · FY2011 · AG · contact PI
MECHANISM OF DISC PROTEOGLYCAN LOSS IN A MOUSE MODEL OF ACCELERATED AGING$178,744
R21 · FY2010 · AG · contact PI